Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNA ENST00000422059 promotes cell proliferation and inhibits cell apoptosis in breast cancer by regulating the miR-145-5p/KLF5 axis. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37997376 | PubTator, text mining | PubMed |
| Deciphering the interaction between Twist1 and PPARγ during adipocyte differentiation. | Cell Death Dis | 2023 | 37996425 | PubTator, text mining | PubMed |
| Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer. | J Korean Med Sci | 2023 | 37987107 | PubTator, text mining | PubMed |
| Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. | Medicine (Baltimore) | 2023 | 37986299 | PubTator, text mining | PubMed |
| Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | 37969742 | PubTator, text mining | PubMed |
| Sources of gene expression variation in a globally diverse human cohort. | bioRxiv | 2023 | 37965206 | PubTator, text mining | PubMed |
| Krüppel-like Factor 10 as a Prognostic and Predictive Biomarker of Radiotherapy in Pancreatic Adenocarcinoma. | Cancers (Basel) | 2023 | 37958386 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers. | Breast Cancer (Dove Med Press) | 2023 | 37954171 | PubTator, text mining | PubMed |
| Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. | Signal Transduct Target Ther | 2023 | 37953273 | PubTator, text mining | PubMed |
| Statistical learning quantifies transposable element-mediated cis-regulation. | Genome Biol | 2023 | 37950299 | PubTator, text mining | PubMed |
| Differentially expressed miR-127, miR-150, and miR-145 in serum extracellular vesicles are novel diagnostic biomarkers of unstable angina. | Cardiovasc Diagn Ther | 2023 | 37941844 | PubTator, text mining | PubMed |
| Exploring molecular mechanisms underlying the pathophysiological association between knee osteoarthritis and sarcopenia. | Osteoporos Sarcopenia | 2023 | 37941536 | PubTator, text mining | PubMed |
| The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. | Basic Res Cardiol | 2023 | 37938421 | PubTator, text mining | PubMed |
| KLF4 suppresses the proliferation of perihilar cholangiocarcinoma by negatively regulating GDF15 and phosphorylating AKT. | Oncol Rep | 2023 | 37937607 | PubTator, text mining | PubMed |
| Single-cell RNA-seq public data reveal the gene regulatory network landscape of respiratory epithelial and peripheral immune cells in COVID-19 patients. | Front Immunol | 2023 | 37936693 | PubTator, text mining | PubMed |
| Longitudinal dynamics of circulating miRNAs in a swine model of familial hypercholesterolemia during early atherosclerosis. | Sci Rep | 2023 | 37935844 | PubTator, text mining | PubMed |
| A review on the role of gamma-butyrobetaine hydroxylase 1 antisense RNA 1 in the carcinogenesis and tumor progression. | Cancer Cell Int | 2023 | 37925403 | PubTator, text mining | PubMed |
| Nanopore long-read RNA sequencing reveals functional alternative splicing variants in human vascular smooth muscle cells. | Commun Biol | 2023 | 37907652 | PubTator, text mining | PubMed |
| Isoform-resolved transcriptome of the human preimplantation embryo. | Nat Commun | 2023 | 37903791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=19